These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
629 related articles for article (PubMed ID: 19088353)
61. Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis. Stein KB; Snyder CF; Barone BB; Yeh HC; Peairs KS; Derr RL; Wolff AC; Brancati FL Dig Dis Sci; 2010 Jul; 55(7):1839-51. PubMed ID: 19731028 [TBL] [Abstract][Full Text] [Related]
62. Diabetes and cancer: a consensus report. Giovannucci E; Harlan DM; Archer MC; Bergenstal RM; Gapstur SM; Habel LA; Pollak M; Regensteiner JG; Yee D CA Cancer J Clin; 2010; 60(4):207-21. PubMed ID: 20554718 [TBL] [Abstract][Full Text] [Related]
63. Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality. Gallagher EJ; LeRoith D Physiol Rev; 2015 Jul; 95(3):727-48. PubMed ID: 26084689 [TBL] [Abstract][Full Text] [Related]
64. Metformin: taking away the candy for cancer? Jalving M; Gietema JA; Lefrandt JD; de Jong S; Reyners AK; Gans RO; de Vries EG Eur J Cancer; 2010 Sep; 46(13):2369-80. PubMed ID: 20656475 [TBL] [Abstract][Full Text] [Related]
65. Elevated insulin receptor content in human breast cancer. Papa V; Pezzino V; Costantino A; Belfiore A; Giuffrida D; Frittitta L; Vannelli GB; Brand R; Goldfine ID; Vigneri R J Clin Invest; 1990 Nov; 86(5):1503-10. PubMed ID: 2243127 [TBL] [Abstract][Full Text] [Related]
66. Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. Jiralerspong S; Palla SL; Giordano SH; Meric-Bernstam F; Liedtke C; Barnett CM; Hsu L; Hung MC; Hortobagyi GN; Gonzalez-Angulo AM J Clin Oncol; 2009 Jul; 27(20):3297-302. PubMed ID: 19487376 [TBL] [Abstract][Full Text] [Related]
67. New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Libby G; Donnelly LA; Donnan PT; Alessi DR; Morris AD; Evans JM Diabetes Care; 2009 Sep; 32(9):1620-5. PubMed ID: 19564453 [TBL] [Abstract][Full Text] [Related]
68. Obesity and cancer: the role of dysfunctional adipose tissue. van Kruijsdijk RC; van der Wall E; Visseren FL Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2569-78. PubMed ID: 19755644 [TBL] [Abstract][Full Text] [Related]
69. Hyperglycaemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthase. Zeng L; Biernacka KM; Holly JM; Jarrett C; Morrison AA; Morgan A; Winters ZE; Foulstone EJ; Shield JP; Perks CM Endocr Relat Cancer; 2010 Jun; 17(2):539-51. PubMed ID: 20356977 [TBL] [Abstract][Full Text] [Related]
70. Metformin and cancer: new applications for an old drug. Kourelis TV; Siegel RD Med Oncol; 2012 Jun; 29(2):1314-27. PubMed ID: 21301998 [TBL] [Abstract][Full Text] [Related]
71. Diabetes mellitus and cancer risk: review of the epidemiological evidence. Shikata K; Ninomiya T; Kiyohara Y Cancer Sci; 2013 Jan; 104(1):9-14. PubMed ID: 23066889 [TBL] [Abstract][Full Text] [Related]
72. Diabetes and Cancer: a Review of Current Knowledge. Wojciechowska J; Krajewski W; Bolanowski M; Kręcicki T; Zatoński T Exp Clin Endocrinol Diabetes; 2016 May; 124(5):263-75. PubMed ID: 27219686 [TBL] [Abstract][Full Text] [Related]
73. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. Tsilidis KK; Kasimis JC; Lopez DS; Ntzani EE; Ioannidis JP BMJ; 2015 Jan; 350():g7607. PubMed ID: 25555821 [TBL] [Abstract][Full Text] [Related]
74. Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer. Renehan AG; Yeh HC; Johnson JA; Wild SH; Gale EA; Møller H; Diabetologia; 2012 Jun; 55(6):1619-32. PubMed ID: 22476948 [TBL] [Abstract][Full Text] [Related]
75. Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature. Liao S; Li J; Wei W; Wang L; Zhang Y; Li J; Wang C; Sun S Asian Pac J Cancer Prev; 2011; 12(4):1061-5. PubMed ID: 21790252 [TBL] [Abstract][Full Text] [Related]
76. Glycaemic control in people with type 2 diabetes mellitus during and after cancer treatment: A systematic review and meta-analysis. Pettit S; Cresta E; Winkley K; Purssell E; Armes J PLoS One; 2017; 12(5):e0176941. PubMed ID: 28467470 [TBL] [Abstract][Full Text] [Related]
77. A prospective study of the associations between treated diabetes and cancer outcomes. Yeh HC; Platz EA; Wang NY; Visvanathan K; Helzlsouer KJ; Brancati FL Diabetes Care; 2012 Jan; 35(1):113-8. PubMed ID: 22100961 [TBL] [Abstract][Full Text] [Related]
79. The causal relationship between diabetes mellitus and the risk of sensorineural hearing loss: A Mendelian randomization study. Guo Q; Niu D; Zhou L Medicine (Baltimore); 2024 Nov; 103(45):e39950. PubMed ID: 39533639 [TBL] [Abstract][Full Text] [Related]
80. The association of diabetes mellitus and routinely collected patient-reported outcomes in patients with cancer. A real-world cohort study. Ose DJ; Adediran E; Mark B; Ocier K; Dunson WA; Turner C; Taylor B; Svoboda K; Post AR; Leiser J; Colman H; Ulrich CM; Hashibe M Cancer Med; 2024 Oct; 13(20):e70246. PubMed ID: 39445809 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]